Financhill
Sell
18

CRSP Quote, Financials, Valuation and Earnings

Last price:
$33.16
Seasonality move :
19.9%
Day range:
$33.03 - $36.97
52-week range:
$30.04 - $67.88
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.47x
Volume:
3.9M
Avg. volume:
2.3M
1-year change:
-41.89%
Market cap:
$2.8B
Revenue:
$35M
EPS (TTM):
-$4.37

CRISPR Therapeutics AG SEC Filings

Company Filed Form Type Description
CRSP
CRISPR Therapeutics AG
11/06/2023 10-Q 10-Q filing on 11/06/2023 View Form
CRSP
CRISPR Therapeutics AG
08/07/2023 10-Q 10-Q filing on 08/07/2023 View Form
CRSP
CRISPR Therapeutics AG
05/08/2023 10-Q 10-Q filing on 05/08/2023 View Form
CRSP
CRISPR Therapeutics AG
11/01/2022 10-Q 10-Q filing on 11/01/2022 View Form
CRSP
CRISPR Therapeutics AG
08/08/2022 10-Q 10-Q filing on 08/08/2022 View Form
CRSP
CRISPR Therapeutics AG
05/09/2022 10-Q 10-Q filing on 05/09/2022 View Form
CRSP
CRISPR Therapeutics AG
11/03/2021 10-Q 10-Q filing on 11/03/2021 View Form
CRSP
CRISPR Therapeutics AG
07/29/2021 10-Q 10-Q filing on 07/29/2021 View Form
CRSP
CRISPR Therapeutics AG
04/27/2021 10-Q 10-Q filing on 04/27/2021 View Form
CRSP
CRISPR Therapeutics AG
02/16/2021 10-K 10-K filing on 02/16/2021 View Form
CRSP
CRISPR Therapeutics AG
10/28/2020 10-Q 10-Q filing on 10/28/2020 View Form
CRSP
CRISPR Therapeutics AG
07/27/2020 10-Q 10-Q filing on 07/27/2020 View Form
CRSP
CRISPR Therapeutics AG
04/28/2020 10-Q 10-Q filing on 04/28/2020 View Form
CRSP
CRISPR Therapeutics AG
02/12/2020 10-K 10-K filing on 02/12/2020 View Form
CRSP
CRISPR Therapeutics AG
10/28/2019 10-Q 10-Q filing on 10/28/2019 View Form
CRSP
CRISPR Therapeutics AG
07/29/2019 10-Q 10-Q filing on 07/29/2019 View Form
CRSP
CRISPR Therapeutics AG
04/29/2019 10-Q 10-Q filing on 04/29/2019 View Form
CRSP
CRISPR Therapeutics AG
02/25/2019 10-K 10-K filing on 02/25/2019 View Form
CRSP
CRISPR Therapeutics AG
11/07/2018 10-Q 10-Q filing on 11/07/2018 View Form
CRSP
CRISPR Therapeutics AG
08/07/2018 10-Q 10-Q filing on 08/07/2018 View Form
CRSP
CRISPR Therapeutics AG
05/08/2018 10-Q 10-Q filing on 05/08/2018 View Form
CRSP
CRISPR Therapeutics AG
03/08/2018 10-K 10-K filing on 03/08/2018 View Form
CRSP
CRISPR Therapeutics AG
11/08/2017 10-Q 10-Q filing on 11/08/2017 View Form
CRSP
CRISPR Therapeutics AG
08/10/2017 10-Q 10-Q filing on 08/10/2017 View Form
CRSP
CRISPR Therapeutics AG
05/11/2017 10-Q 10-Q filing on 05/11/2017 View Form
CRSP
CRISPR Therapeutics AG
03/10/2017 10-K 10-K filing on 03/10/2017 View Form
CRSP
CRISPR Therapeutics AG
11/22/2016 10-Q 10-Q filing on 11/22/2016 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Is Berkshire The Best Stock to Buy in a Bad Market?
Is Berkshire The Best Stock to Buy in a Bad Market?

Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…

Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?

The big picture trends in e‑commerce sales are clearly in…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
60
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 7

Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.

Buy
77
FARO alert for May 7

Faro Technologies [FARO] is up 34.66% over the past day.

Buy
63
SKX alert for May 7

Skechers USA [SKX] is down 0.07% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock